Used in the synthesis of pharmaceuticals, particularly in the development of compounds targeting central nervous system disorders. It serves as a key intermediate in the production of drugs with potential antidepressant or anxiolytic properties. The trifluoromethoxy group enhances the molecule's ability to cross the blood-brain barrier, making it valuable in neuroactive drug design. Additionally, its cyclopropyl structure contributes to the stability and bioavailability of the final drug product.